MDxHealth brain tumour test included in U.S. cancer guidelines

BRUSSELS Wed Oct 16, 2013 2:00am EDT

Related Topics

BRUSSELS Oct 16 (Reuters) - Belgian-based cancer testing company MDxHealth said on Wednesday that its brain tumour test PredictMDx had been included in the guidelines of the U.S. National Comprehensive Cancer Network, meaning it would be made available to more U.S. patients.

To be included in the network as well as being awarded a national reimbursement code by the America Medical Association cleared the way for comprehensive reimbursement of the test in the United States, MDxHealth said.

The PredictMDx test gives doctors better insight into whether certain types of treatment work with a patient or not. (Reporting by Robert-Jan Bartunek; editing by Philip Blenkinsop)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

A tourist takes a plunge as she swims at Ngapali Beach, a popular tourist site, in the Thandwe township of the Rakhine state, October 6, 2013. Picture taken October 6, 2013. REUTERS/Soe Zeya Tun (MYANMAR - Tags: SOCIETY) - RTR3FOI0

Where do you want to go?

We look at when to take trips, budget considerations and the popularity of multigenerational family travel.   Video